Vicebio
Chemicals & Related Products · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
168 Shoreditch High St Fl 2, London, Gre...Website
www.vicebio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Vicebio
Vicebio is a biotechnology company focused on redefining respiratory disease prevention through innovative vaccine solutions. Utilizing their proprietary Molecular Clamp technology, they develop next-generation vaccines that provide broad protection and are easy to manufacture. The company is committed to addressing significant global health challenges with a robust pipeline of multipathogen respiratory vaccines. Their target clients include healthcare providers and organizations seeking advanced solutions for respiratory disease management.Explore more
Popular SearchesVicebio LtdViceBioSIC Code 28,283NAICS Code 32,325Show moreVicebio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vicebio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Vicebio has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Vicebio has new funding data
Vicebio, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Vicebio
Check out if Vicebio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Vicebio recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Vicebio had a recent Job posting/layoffs
Product Launch: Get notified when Vicebio launches new products
Recommended Actions
Reach out to Masked Content who joined Vicebio as Masked Content
Find more new buyers
Compare Similar Companies to Vicebio
Compare insights from companies similar to Vicebio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vicebio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vicebio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vicebio.
Vicebio financials insights
Gather financial insights about Vicebio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series B
$100M
Vicebio News & Media
Press Release: Sanofi completes acquisition of Vicebio
Sanofi completes acquisition of Vicebio Paris, December 4, 2025. Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”). This...Sanofi to acquire next-gen vaccine biotech Vicebio for $1.6 billion
Vicebio, a biopharmaceutical company developing vaccines against life-threatening respiratory viral infections, has entered an exclusive, definitive agreement to be acquired by Sanofi.Sanofi Makes $1.6B Vaccine Bet With Vicebio Acquisition - BioSpace
The acquisition, which will give Sanofi a combination vaccine for respiratory syncytial virus and human metapneumovirus, follows the pharma’s potential $1.4 billion COVID vaccine licensing deal with Novavax last year, plus a number of other big-ticket commitments outside of the vaccine space.Sanofi to expand respiratory vaccines pipeline with $1.6bn Vicebio acquisition - PMLiVE
The deal includes an early-stage combination vaccine candidate for RSV and hMPV
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vicebio
Sign Up For FreeTo access detailed company insights
Vicebio is a biotechnology company focused on redefining respiratory disease prevention through innovative vaccine solutions. Utilizing their proprietary Molecular Clamp technology, they develop next-generation vaccines that provide broad protection and are easy to manufacture. The company is committed to addressing significant global health challe... Read More
